Yüklüyor......
Meta-analysis of effect of vernakalant on conversion of atrial fibrillation
BACKGROUND: In recent years, there has been a large amount of studies about the efficacy and safety of vernakalant or RSD1235, an antiarrhythmic agent, in treating the atrial fibrillation (AF). This study was designed to assess the efficacy and safety of vernakalant in the treatment of AF. RESULTS:...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3610119/ https://ncbi.nlm.nih.gov/pubmed/23497611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-94 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|